Ratings by TD Cowen (Stacy Ku)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/29/2026 | Sol Gel Technologies Ltd. | SLGL | New Coverage | Buy (N/A) |
75.28 (74.46) |
-1.09% | Details | |
| 5/4/2026 | Tonix Pharma | TNXP | New Coverage | Buy (N/A) |
13.60 (12.01) |
-11.69% | Details | |
| 4/23/2026 | Grace Therapeutics | GRCE | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2026 | Protara Therapeutics | TARA | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | BioCryst Pharma | BCRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2026 | Supernus Pharmaceuticals | SUPN | Maintain | (N/A) |
|
Details | ||
| 2/24/2026 | Avalo Therapeutics Inc. | AVTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2026 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2026 | Centessa Pharmaceuticals | CNTA | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2026 | Verrica Pharmaceuticals | VRCA | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2025 | BioCryst Pharma | BCRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2025 | DiaMedica Therapeutics Inc. | DMAC | New Coverage | Buy (N/A) |
6.69 (5.85) |
-12.56% | Details | |
| 10/23/2025 | Supernus Pharmaceuticals | SUPN | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2025 | BioCryst Pharma | BCRX | New Coverage | Buy (N/A) |
7.04 (8.99) |
27.7% | Details | |
| 9/5/2025 | Avalo Therapeutics Inc. | AVTX | New Coverage | Buy (N/A) |
10.16 (14.70) |
44.69% | Details | |
| 8/13/2025 | Verrica Pharmaceuticals | VRCA | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2025 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2025 | Grace Therapeutics | GRCE | New Coverage | Buy (N/A) |
2.71 (2.38) |
-12.18% | Details | |
| 3/18/2025 | LENZ Therapeutics Inc | LENZ | Upgrade | Buy (N/A) |
25.45 (6.15) |
-75.83% | Details | |
| 3/5/2025 | Centessa Pharmaceuticals | CNTA | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2025 | Centessa Pharmaceuticals | CNTA | New Coverage | Buy (N/A) |
16.74 (40.02) |
139.07% | Details | |
| 1/7/2025 | Kalvista Pharmaceuticals Inc | KALV | New Coverage | Buy (N/A) |
8.68 (27.00) |
211.06% | Details | |
| 12/5/2024 | Protera Therapeutics | TARA | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2024 | Astria Therapeutics | ATXS | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2024 | Verrica Pharmaceuticals | VRCA | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2024 | Astria Therapeutics | ATXS | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2024 | Protera Therapeutics | TARA | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Astria Therapeutics | ATXS | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2024 | Protera Therapeutics | TARA | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2024 | Astria Therapeutics | ATXS | New Coverage | Buy (N/A) |
11.93 (12.58) |
5.45% | Details | |
| 6/25/2024 | BioCryst Pharma | BCRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2024 | Protera Therapeutics | TARA | Maintain | Buy (N/A) |
|
Details | ||
| 2/15/2024 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2020 | Momenta Pharmaceuticals | MNTA | Upgrade | Buy (Hold) |
29.49 (52.48) |
77.96% | Details |
